Galapagos NV
GLPG
#5036
Rank
ยฃ1.39 B
Marketcap
ยฃ20.76
Share price
0.00%
Change (1 day)
-17.36%
Change (1 year)

Galapagos NV (GLPG) - Net assets

Net assets on the balance sheet as of March 2026 : ยฃ2.81 Billion

According to Galapagos NV's latest financial reports the company has ยฃ2.81 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Galapagos NV - Net assets on balance sheet (from 2008 to 2026)

Net assets by year

Year Net assets Change
2024-12-31$ยฃ2.40 B-0.97%
2023-12-31$ยฃ2.42 B8.31%
2022-12-31$ยฃ2.23 B0.99%
2021-12-31$ยฃ2.21 B-7.96%
2020-12-31$ยฃ2.40 B-1.91%
2019-12-31$ยฃ2.45 B124.49%
2018-12-31$ยฃ1.09 B21.8%
2017-12-31$ยฃ0.89 B38.91%
2016-12-31$ยฃ0.64 B140.16%
2015-12-31$ยฃ0.26 B67.24%
2014-12-31$ยฃ0.16 B15.08%
2013-12-31$ยฃ0.13 B44.35%
2012-12-31$ยฃ96.93 M-1.99%
2011-12-31$ยฃ98.9 M-22.71%
2010-12-31$ยฃ0.12 B32.74%
2009-12-31$ยฃ96.39 M19.85%
2008-12-31$ยฃ80.43 M10.96%
2007-12-31$ยฃ72.48 M-1.77%
2006-12-31$ยฃ73.79 M75.71%
2005-12-31$ยฃ41.99 M473.32%
2004-12-31$ยฃ7.32 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
ยฃ63.61 B 2,156.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
ยฃ39.45 B 1,299.57%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
-ยฃ4.41 Billion-256.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ59.44 B 2,008.58%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
ยฃ31.43 B 1,014.96%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ37.70 B 1,237.66%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
ยฃ17.03 B 504.45%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
ยฃ0.15 B-94.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ5.80 B 106.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel